Clinical Trial: A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Study Status: Completed
Recruit Status: RECRUITING
Condition: Hidradenitis Suppurativa
Study Type: INTERVENTIONAL
Official Title: A Parallel-group Treatment, Phase 2, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAR444656 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Brief Summary:
This is a parallel, Phase 2, 2-arm study to evaluate the efficacy, safety, PK, and biological effects of SAR444656 compared with placebo in adult participants with moderate to severe HS aged ?18 to 70 years.Study details include:Screening period: up to 4 weeks (30 days)Treatment duration: up to 16 weeksFollow-up period: up to 4 weeksTotal study duration: up to 24 weeksNumber of visits: 14
Read more